STOCK TITAN

BioVie (BIVI) director makes open-market share purchase

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BIOVIE INC. (BIVI) director Amy Suzon Chappell purchased 727 shares of Common Stock on 2026-08-28 in an open market transaction at $2.16 per share. Following this reported transaction, she directly owns 727 shares of BIOVIE INC. common stock.

Positive

  • None.

Negative

  • None.
Insider Chappell Amy Suzon
Role Director
Bought 727 shs ($2K)
Type Security Shares Price Value
Purchase Common Stock F1 727 $2.16 $2K
Holdings After Transaction: Common Stock — 727 shares (Direct)
Footnotes (1)
  1. F1. The shares of Common Stock were purchased by the Reporting Person in an open market transaction.
Shares purchased 727 shares of Common Stock Open market purchase on 2026-08-28
Purchase price per share $2.16 per share Open market transaction on 2026-08-28
Total shares owned after transaction 727 shares Direct ownership following reported purchase
open market transaction market
"shares of Common Stock were purchased ... in an open market transaction"
An open market transaction is a buy or sell of publicly traded securities executed on an exchange or other public trading venue where many buyers and sellers can participate. It matters to investors because these trades change the visible supply and demand for a stock—like shoppers moving prices in a busy marketplace—affecting share price, liquidity (how easily you can trade), and sometimes the balance of ownership.
Common Stock financial
"security_title: Common Stock, transaction_date: 2026-08-28"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
direct ownership financial
"direct_or_indirect: D indicates direct ownership of the shares"

FAQ

What insider transaction did BIVI report for Amy Suzon Chappell?

BIOVIE INC. reported that director Amy Suzon Chappell bought 727 shares of its Common Stock on 2026-08-28 in an open market transaction at $2.16 per share, resulting in total direct holdings of 727 shares.

Was the recent BIVI insider trade by Amy Suzon Chappell a purchase or a sale?

The reported BIVI insider trade by Amy Suzon Chappell was a purchase. She acquired 727 shares of BIOVIE INC. Common Stock at $2.16 per share in an open market transaction on 2026-08-28.

How many BIOVIE INC. (BIVI) shares does Amy Suzon Chappell hold after the transaction?

After the reported transaction, Amy Suzon Chappell directly holds 727 shares of BIOVIE INC. Common Stock, according to the Form 4 filing.

At what price were the recently purchased BIVI shares acquired by Amy Suzon Chappell?

The recently purchased BIOVIE INC. (BIVI) shares were acquired by Amy Suzon Chappell at a price of $2.16 per share in an open market transaction on 2026-08-28.

Was the BIVI insider transaction by Amy Suzon Chappell under a Rule 10b5-1 plan?

No. The filing indicates the Rule 10b5-1 checkbox is not affirmed, and the footnote clarifies only that the 727 shares were purchased in an open market transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chappell Amy Suzon

(Last)(First)(Middle)
C/O BIOVIE INC.
680 W NYE LANE STE 201

(Street)
CARSON CITY NEVADA 89703

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BIOVIE INC. [ BIVI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/28/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/28/2026P727(1)A$2.16727D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The shares of Common Stock were purchased by the Reporting Person in an open market transaction.
/s/ Joanne Wendy Kim, attorney-in-fact for Amy Suzon Chappell08/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)